Study on COgnition and Prognosis in the Elderly (SCOPE)

L Hansson1, H Lithell, I Skoog

  • 1University of Uppsala, Department of Public Health, Sweden.

Blood Pressure
|December 14, 1999
PubMed

Insights

The SCOPE trial investigated candesartan cilexetil for mild hypertension in elderly patients. It assessed cardiovascular events, cognitive function, and mortality, providing key insights into hypertension management in seniors.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Mild hypertension in the elderly is common, posing significant cardiovascular risks.
  • Effective management strategies are crucial to improve prognosis and quality of life in this demographic.

Purpose of the Study:

  • To evaluate the efficacy of candesartan cilexetil versus placebo in reducing major cardiovascular events in elderly patients with mild hypertension.
  • To assess the impact of candesartan cilexetil on cognitive function, mortality, and health economics.

Main Methods:

  • A multicentre, prospective, randomized, double-blind, parallel-group study (SCOPE) involving 4964 elderly patients (70-89 years).
  • Patients received either candesartan cilexetil or placebo, with dosage adjustments based on blood pressure.
  • Primary endpoint: major cardiovascular events. Secondary endpoints included cognitive function, mortality, and quality of life.

Main Results:

  • Recruitment completed with 4964 randomized patients.
  • Follow-up duration is 2 years, potentially longer if event rates are low.
  • The study aims to provide comprehensive data on the benefits and risks of candesartan cilexetil in this population.

Conclusions:

  • The SCOPE study provides valuable data on the cardiovascular and cognitive effects of candesartan cilexetil in elderly hypertensive patients.
  • Findings will inform clinical practice regarding hypertension management in older adults.
  • Further analysis will elucidate the drug's impact on mortality, renal function, and health economics.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitivism01:17

Cognitivism

Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process information is...
Introduction to Cognitive Psychology01:20

Introduction to Cognitive Psychology

Cognitive psychology is the field of psychology dedicated to examining how people think. It attempts to explain how and why we think the way we do by studying the interactions among human thinking, emotion, creativity, language, and problem-solving, as well as other cognitive processes. Cognitive psychology studies how information is processed and manipulated in remembering, thinking, and knowing.
This field emerged in the mid-20th century, following a period dominated by behaviorism, which...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...